JPH0647554B2 - Testosterone 5α-reductase inhibitor - Google Patents

Testosterone 5α-reductase inhibitor

Info

Publication number
JPH0647554B2
JPH0647554B2 JP2119057A JP11905790A JPH0647554B2 JP H0647554 B2 JPH0647554 B2 JP H0647554B2 JP 2119057 A JP2119057 A JP 2119057A JP 11905790 A JP11905790 A JP 11905790A JP H0647554 B2 JPH0647554 B2 JP H0647554B2
Authority
JP
Japan
Prior art keywords
testosterone
tsr
action
peppermint
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2119057A
Other languages
Japanese (ja)
Other versions
JPH0418026A (en
Inventor
達郎 山村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2119057A priority Critical patent/JPH0647554B2/en
Publication of JPH0418026A publication Critical patent/JPH0418026A/en
Publication of JPH0647554B2 publication Critical patent/JPH0647554B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 <産業上の利用分野> 本発明は、育毛・養毛、ニキビ用の化粧料や医薬品等に
応用可能で、かつ副作用のない、テストステロン5α−
リダクターゼ阻害剤に関する。
DETAILED DESCRIPTION OF THE INVENTION <Industrial field of application> The present invention is applicable to hair growth / hair growth, acne cosmetics and pharmaceuticals, and has no side effects, and testosterone 5α-
It relates to a reductase inhibitor.

<従来の技術> 男性型禿頭や脱毛症、あるいは脂漏、ニキビ(尋常性ざ
瘡)等は、男性ホルモンの過剰によるといわれている。
特に、毛根、皮脂腺等の器官におけるこの男性ホルモン
活性の本体は、これら標的器官においてテストステロン
がテストステロン5α−リダクターゼ(TSR)によっ
て還元されて生成する、5α−ジヒドロテストステロン
(DHT)であることが知られている。すなわち、精巣
や副腎で生合成され分泌されたテストステロン(男性ホ
ルモン)は、血流によって皮脂腺に到達し、皮脂腺細胞
中のTSRによってDHTに変換される。このDHTは
細胞内の受容体と結合し、核に作用して皮脂腺細胞の増
殖を促す一方、毛母細胞にも作用してその細胞分裂を抑
制し、毛の成長を妨げるものとされている。
<Prior Art> Male baldness, alopecia, seborrhea, acne (acne vulgaris), etc. are said to be due to an excess of male hormones.
In particular, it is known that the main body of this androgen activity in organs such as hair roots and sebaceous glands is 5α-dihydrotestosterone (DHT), which is produced by reducing testosterone by testosterone 5α-reductase (TSR) in these target organs. ing. That is, testosterone (male hormone) biosynthesized and secreted in the testis and adrenal reaches the sebaceous gland by the bloodstream and is converted into DHT by TSR in the sebaceous gland cells. This DHT binds to an intracellular receptor and acts on the nucleus to promote the growth of sebaceous gland cells, while it also acts on hair mother cells to suppress cell division and prevent hair growth. .

従来、男性型禿頭や脱毛症またはニキビ等の治療には、
エストラジオール等の女性ホルモン作用を有する物質
や、酢酸シプロテロン等の抗男性ホルモン作用を有する
物質、強い酸化力を有する物質二酸化塩素(ClO
等)が用いられていた。また、上記のテストステロン
の作用機序に着目し、TSR活性を阻害する物質の研究
も進められている。
Conventionally, for the treatment of male pattern baldness, alopecia or acne,
Substances having female hormone action such as estradiol, substances having anti-androgen action such as cyproterone acetate, substance having strong oxidizing power Chlorine dioxide (ClO)
2 ) was used. In addition, focusing on the mechanism of action of testosterone described above, research on substances that inhibit TSR activity is also underway.

<発明が解決しようとする課題> しかし、ホルモン剤や酸化剤は副作用や安全性の面で問
題があり、化粧料への配合が不可能なものや、医師の管
理下でのみ使用が可能なものばかりであった。
<Problems to be solved by the invention> However, hormones and oxidants have side effects and safety problems, and cannot be incorporated into cosmetics, or can be used only under the supervision of a doctor. There were only things.

また、TSR活性を阻害する物質として報告されている
ものも、その作用・効果が不十分であったり、安全性が
十分でなかったり、あるいはコスト的に高価であったり
と、種々の問題が存在する。
Also, substances reported as substances that inhibit TSR activity have various problems such as insufficient action / effect, insufficient safety, or high cost. To do.

<課題を解決するための手段> 我々は長年にわたり、副作用や安全性の面で問題がな
く、化粧料等に配合の可能な薬草抽出物のスクリーニン
グを行ってきた。そして上記の課題についても、特定の
薬草抽出物の応用が有効であることを見い出した。
<Means for Solving the Problems> For many years, we have been screening herbal extracts that have no side effects or safety problems and can be incorporated into cosmetics. Then, it has been found that the application of a specific herbal extract is effective for the above problems.

すなわち、薬草の乾燥粉末を99.5%または50%エタノー
ルに1g/10mlの割合で各々浸漬し、1週間静置した後
ろ過し、ろ液を分離してTSR活性を調べた。その結
果、セージ(Salvia officinalis L.)、ホップ(Humulus
lupulus L.)、ローズマリー(Rosmarinus officinalis
L.)、オトギリソウ(Hypericum erectum Thunb.)、ハッ
カ(Mentha arvensis L.var.piperascens Malinv.)、セ
イヨウハッカ(Mentha piperita L.)、カミツレ(Matrica
ria chamomilla L.)、アルニカ(Arnica montana L.)、
タイム(Thymus vulgaris L.)の各エタノール抽出物が有
効であることを見い出した。
That is, dry powder of medicinal herbs was immersed in 99.5% or 50% ethanol at a ratio of 1 g / 10 ml, and allowed to stand for 1 week and then filtered, and the filtrate was separated to examine the TSR activity. As a result, sage ( Salvia officinalis L.), hop ( Humulus
lupulus L.), rosemary ( Rosmarinus officinalis
L.), St. John's wort (Hypericum erectum Thunb.), Peppermint (Mentha arvensis L.var. Piperascens Malinv. ), Peppermint (Mentha piperita L.), chamomile (Matrica
ria chamomilla L.), Arnica montana L.),
It was found that each ethanol extract of Thyme ( Thymus vulgaris L.) was effective.

<作用> 表1に上記薬草抽出物のTSR活性阻害率、及びタンパ
ク変性率を示す。
<Action> Table 1 shows the TSR activity inhibition rate and protein denaturation rate of the above herbal extracts.

TSR液として、ラット肝臓のホモジネートの9,000xg
上清(S−9)を用いた。まず、テストステロン3μl
をプロピレングリコール10滴に溶解し、Tris-HCl緩衝液
(pH7.2)5mlを加える。これに、NADPH5mg、S−9
1ml、及び薬草抽出物0.5mlを加え、37℃で30分間イン
キュベートした後、ジクロロメタン50mlを加えて反応を
停止させ、ジクロロメタン層を分取し減圧乾燥した後、
ガスクロマトグラフィ−(GC)にて反応生成物である
DHT、アンドロスタンジオール等を検出定量した(G
C条件:カラム;ULBON HR-1,キャリアーガス;He 20m
l/min,カラム温度;200℃)。TSR活性阻害率は薬草
抽出物無添加時(コントロール)の反応生成物量と、薬
草抽出物添加時の反応生成物量の比較により求めた。
Rat liver homogenate as TSR solution 9,000xg
The supernatant (S-9) was used. First, testosterone 3 μl
Is dissolved in 10 drops of propylene glycol, and 5 ml of Tris-HCl buffer (pH 7.2) is added. To this, NADPH 5mg, S-9
After adding 1 ml and 0.5 ml of the herb extract and incubating at 37 ° C. for 30 minutes, 50 ml of dichloromethane was added to stop the reaction, and the dichloromethane layer was separated and dried under reduced pressure.
Gas chromatography (GC) was used to detect and quantify reaction products such as DHT and androstanediol (G
C condition: column; ULBON HR-1, carrier gas; He 20m
l / min, column temperature; 200 ° C). The TSR activity inhibition rate was determined by comparing the amount of the reaction product when the herb extract was not added (control) with the amount of the reaction product when the herb extract was added.

一方、タンパク変性率は、0.02%卵白アルブミンを含む
0.15M硫酸ナトリウム/0.05Mリン酸緩衝液(pH7.0)9m
lに薬草抽出物1mlを加え、5分間攪拌した後、メンブ
ランフィルターでろ過し、高速液体クロマトグラフィ−
(カラム:TSK-gel G-3000SW)でアルブミンを定量して
求めた。
On the other hand, the protein denaturation rate includes 0.02% ovalbumin.
0.15M sodium sulfate / 0.05M phosphate buffer (pH7.0) 9m
Add 1 ml of the herb extract to 1 l, stir for 5 minutes, filter with a membrane filter, and perform high performance liquid chromatography.
(Column: TSK-gel G-3000SW) was used to quantify albumin.

No.1〜8の各薬草抽出物については、99.5%あるい
は50%エタノールのいずれの抽出物も高いTRS活性阻
害率を示した。これらのタンパク変性率は、ローズマリ
ー(No.3)の99.5%エタノール抽出物及びオトギリ
ソウ(No.4)の50%エタノール抽出物において若干
高い値を示したものの、概ね低い値であった。従って、
これら薬草抽出物は高いTSR活性阻害作用を示し、か
つこの作用は酵素タンパク質の変性によるものではなか
った。
No. Regarding the herbal extracts 1 to 8, both 99.5% and 50% ethanol extracts showed a high TRS activity inhibition rate. These protein denaturation rates were slightly low in the 99.5% ethanol extract of rosemary (No. 3) and the 50% ethanol extract of Hypericum (No. 4), but were low in general. Therefore,
These herbal extracts showed a high inhibitory effect on TSR activity, and this effect was not due to denaturation of the enzyme protein.

No.9のリンデン抽出物はTSR活性阻害率が高いも
のの、タンパク変性率も92.21%と大きく、酵素タンパク
質の変性による阻害作用を有すると思われ、我々の目的
には好ましくない。
No. Although the lindane extract of 9 has a high TSR activity inhibitory rate, it has a large protein denaturation rate of 92.21% and is considered to have an inhibitory effect due to the denaturation of enzyme protein, which is not preferable for our purposes.

No.10〜15の各薬草抽出物については、有意なTSR
活性阻害作用は認められなかった。
No. Significant TSR for each of 10-15 herbal extracts
No activity inhibitory effect was observed.

なお、この測定系においてエタノールの影響は認められ
なかった。
The effect of ethanol was not observed in this measurement system.

さらに、上記8種の薬草抽出物中には、皮脂腺の脂質生
合成を抑制する作用を示すものが存在する。すなわち、
10週令のゴールデンハムスターの耳介皮膚の器官培養に
おいて、脂質生合成の阻害が認められた。器官培養はハ
ムスター耳介皮膚片(6mmφ)より内側皮膚を剥離して
軟骨を除去した後、[14C]−酢酸ナトリウム4.4μ
Ciと試料液20μlを添加した培養液(10%FMS含有Eagl
e MEM培地にペニシリン、ストレプトマイシン、ファン
ギゾン、L−グルタミンを添加したもの)2mlに表皮側
が上になるように浮かせて、37℃で6時間行った。対照
としてもう一方の耳介皮膚を、試料液の代わりに溶媒の
みを添加した培養液で培養した。培養後、生理食塩水で
洗浄し、2N NaBr液に入れて37℃で1時間静置した
後、真皮と表皮を分離し、得られた真皮シートをクロロ
ホルム:メタノール(2:1)2mlに入れ、12時間脂質
の抽出を行った。脂質生合成の阻害率は、[14C]−
酢酸ナトリウムの取り込み阻害率として求め、結果を第
1図に示した。
Furthermore, among the above eight herbal extracts, there are some that exhibit an action of suppressing lipid biosynthesis in the sebaceous glands. That is,
Inhibition of lipid biosynthesis was observed in organ cultures of auricular skin of 10-week-old golden hamsters. The organ culture was carried out by removing the cartilage by peeling the inner skin from a hamster ear piece (6 mmφ), and then [ 14 C] -sodium acetate 4.4 μm.
Culture medium containing 20 μl of Ci and sample solution (Eagl containing 10% FMS
2 ml of eMEM medium to which penicillin, streptomycin, fungizone, and L-glutamine were added) was floated so that the epidermis side was facing up, and the incubation was carried out at 37 ° C for 6 hours. As a control, the other auricle skin was cultivated in a culture medium containing only the solvent instead of the sample solution. After culturing, wash with physiological saline, put in 2N NaBr solution, leave at 37 ° C for 1 hour, separate dermis and epidermis, put the obtained dermal sheet in 2 ml of chloroform: methanol (2: 1). The lipids were extracted for 12 hours. The inhibition rate of lipid biosynthesis is [ 14 C]-
The inhibition rate of sodium acetate uptake was determined, and the results are shown in FIG.

ホップ(Humulus lupulus L.)抽出液及びローズマリー
Rosmarinus officinalis L.)抽出液において顕著な
取り込み抑制が認められた。これらの抑制率は各々46.2
1%及び19.89%であり、一般に脂質生合成を抑制するとい
われるビタミンである塩酸ピリドキシンよりも高い抑制
率を示した。この脂質生合成抑制作用は、TSR活性阻
害を介する可能性が高い。
Significant suppression of uptake was observed in the hop ( Humulus lupulus L.) extract and the rosemary ( Rosmarinus officinalis L.) extract. These suppression rates are 46.2 each
The values were 1% and 19.89%, respectively, showing a higher inhibition rate than pyridoxine hydrochloride, which is a vitamin generally said to inhibit lipid biosynthesis. This lipid biosynthesis inhibitory action is likely to be mediated by inhibition of TSR activity.

また、一般に、培養系における[14C]ラベル物質取
り込みによる生合成実験では、ホルモン作用による生合
成の促進、抑制は培養後12時間以上経過しないと出現し
ないことが知られている(V.Wheatly and J.Brind;J.I
nvest.Dermatol.76 293-296,1981)。従って、上記の
作用はホルモン作用を介するものではなく、重篤な副作
用の生ずる心配がない。
In addition, it is generally known that, in a biosynthesis experiment by incorporation of [ 14 C] -labeled substance in a culture system, promotion and inhibition of biosynthesis by hormone action do not appear until 12 hours or more after culture (V. Wheatly. and J.Brind ; JI
nvest.Dermatol. 76 293-296, 1981). Therefore, the above-mentioned effects are not mediated by hormones, and there is no concern that serious side effects will occur.

<効果> 以上のように、セージ(Salvia officinalis L.)、ホッ
プ(Humulus lupulus L.)、ローズマリー(Rosmarinus of
ficinalis L.)、オトギリソウ(Hypericum erectum Thun
b.)、ハッカ(Mentha arvensis L.var.piperascens Mali
nv.)、セイヨウハッカ(Mentha piperita L.)、カミツレ
(Matricaria chamomilla L.)、アルニカ(Aunica montan
a L.)、タイム(Thymus vulgaris L.)のエタノール抽出
物は、TSR阻害作用及び皮脂生成抑制作用を示す。従
って、これらより1種または2種以上を選択してTSR
阻害剤として、養毛・育毛剤あるいは毛髪用化粧料、ま
たはニキビ治療用皮膚外用剤や皮膚化粧料に配合するこ
とができる。その際、上記作用がタンパク変性作用やホ
ルモン作用によるものではないので、皮膚に対する刺激
や副作用のない安全な化粧料等を提供することができ
る。
<Effect> As described above, sage ( Salvia officinalis L.), hops ( Humulus lupulus L.), rosemary ( Rosmarinus of
ficinalis L.), Hypericum ( Hypericum erectum Thun)
b.), peppermint (Mentha arvensis L.var. piperascens Mali
nv.), European peppermint ( Mentha piperita L.), chamomile
( Matricaria chamomilla L.), Arnica ( Aunica montan
a .) and thyme ( Thymus vulgaris L.) ethanol extracts exhibit TSR inhibitory action and sebum production inhibitory action. Therefore, select one or two or more of these from the TSR.
As an inhibitor, it can be incorporated into a hair nourishing / hair-growth agent or a hair cosmetic, or a skin external preparation for treating acne or a skin cosmetic. In that case, since the above-mentioned action is not due to protein denaturing action or hormonal action, it is possible to provide a safe cosmetic or the like which is free from skin irritation and side effects.

【図面の簡単な説明】[Brief description of drawings]

第1図は脂質生合成の阻害率を表す[14C]−酢酸ナ
トリウムの取り込み阻害を示す図である。
FIG. 1 is a diagram showing inhibition of [ 14 C] -sodium acetate uptake, which represents the inhibition rate of lipid biosynthesis.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】セージ(Salvia officinalis L.)、ホップ
(Humulus lupulus L.)、ローズマリー(Rosmarinus offi
cinalis L.)、オトギリソウ(Hypericum erectum Thun
b.)、ハッカ(Mentha arvensis L.var.piperascens Mali
nv.)、セイヨウハッカ(Mentha piperita L.)、カミツレ
(Matricaria chamomilla L.)、アルニカ(Arnica montan
a L.)、タイム(Thymus vulgaris L.)のエタノール抽出
物より選択した、1種または2種以上よりなるテストス
テロン5α−リダクターゼ阻害剤。
1. Sage ( Salvia officinalis L.), hop
( Humulus lupulus L.), rosemary ( Rosmarinus offi
cinalis L.), Hypericum ( Hypericum erectum Thun)
b.), peppermint (Mentha arvensis L.var. piperascens Mali
nv.), European peppermint ( Mentha piperita L.), chamomile
( Matricaria chamomilla L.), Arnica montan
a .), Thymus vulgaris L.), and one or more testosterone 5α-reductase inhibitors selected from the ethanol extract.
JP2119057A 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor Expired - Fee Related JPH0647554B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2119057A JPH0647554B2 (en) 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2119057A JPH0647554B2 (en) 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor

Publications (2)

Publication Number Publication Date
JPH0418026A JPH0418026A (en) 1992-01-22
JPH0647554B2 true JPH0647554B2 (en) 1994-06-22

Family

ID=14751840

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2119057A Expired - Fee Related JPH0647554B2 (en) 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor

Country Status (1)

Country Link
JP (1) JPH0647554B2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039157A1 (en) * 1994-11-08 1996-12-12 Taisho Pharmaceutical Co., Ltd. TESTOSTERONE 5α-REDUCTASE INHIBITOR
JPH0873324A (en) * 1994-09-06 1996-03-19 Kao Corp Hair nourishment
CN1076380C (en) * 1995-01-13 2001-12-19 金坚敏 Efficient natural antioxidants and their preparation
ES2147538B1 (en) * 1999-01-29 2001-04-01 Revlon Consumer Prod Corp A CAPILLARY LOTION WITH IMPROVED PROPERTIES IN ITS HAIR PROTECTIVE AND PREVENTIVE ACTION OF HIS FALL, AND REDUCTION OF THE EXTERNAL EFFECTS OF ANDROGENETIC ALOPECIA AND WITH THAT OF THE HAIR FALL.
JP2001122777A (en) 1999-10-27 2001-05-08 Nagase & Co Ltd Antiulcer agent
ES2157850B1 (en) * 1999-12-28 2002-02-16 Perdigon Jose Diaz NATURAL CAPILLARY REGENERATOR AND PROCEDURE FOR MANUFACTURING.
DE10114304A1 (en) * 2001-03-23 2002-10-02 Beiersdorf Ag Cosmetic and dermatological preparations containing hops or hops-malt extract and use of a hop or hops malt extract for the preparation of cosmetic and dermatological preparations for the reduction of the sebum content of the skin
JP4999276B2 (en) * 2005-02-09 2012-08-15 丸善製薬株式会社 Hair papilla cell growth promoter and hair restorer
JP6322368B2 (en) * 2013-07-16 2018-05-09 日華化学株式会社 Hair cosmetic and skin cosmetic containing PGD2 production inhibitor and 5α-reductase activity inhibitor
JP2016006021A (en) * 2014-06-20 2016-01-14 株式会社ノエビア Thioredoxin-related factor expression promoter
CN116211763B (en) * 2022-12-30 2025-08-08 中山市天图精细化工有限公司 Foam type hair oil-control no-clean fluffy aerosol composition and preparation method thereof
CN118557489B (en) * 2024-07-31 2024-10-29 霸王(广州)有限公司 A kind of antibacterial and oil-controlling composition and its preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5133166B2 (en) * 1971-11-25 1976-09-17
JPS60146829A (en) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk Testosterone 5alpha-reductase inhibitor
JP2676155B2 (en) * 1988-08-11 1997-11-12 株式会社資生堂 Hair restoration
JP2871763B2 (en) * 1989-12-15 1999-03-17 株式会社資生堂 Testosterone-5α-reductase inhibitor

Also Published As

Publication number Publication date
JPH0418026A (en) 1992-01-22

Similar Documents

Publication Publication Date Title
JPH0647554B2 (en) Testosterone 5α-reductase inhibitor
JP3177642B2 (en) Antiandrogens
JP2018087187A (en) Hair loss prevention or hair growth promoting composition containing sophorolipid as an active ingredient
EP1430883B1 (en) Cosmetic use of ascorbic acid derivatives as whitening agents for skin or hair
JPH01311011A (en) Melanization inhibitory drug for external use
JP5085018B2 (en) Hair restorer
FR2791255A1 (en) PLANT COMPLEX ENTERING INTO COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS LIMITING THE DEVELOPMENT OF HAIR BULB, STIMULATING THE HAIR SYSTEM AND USED FOR THE TREATMENT OF SEBORRHEIC SKIN
JPH08310923A (en) Testosterone 5alpha-reductase inhibitor
FR2837704A1 (en) Use of sapogenins or compositions or natural extracts containing them to treat dry skin or scalp or associated disorders
CN110613629A (en) Whitening composition and preparation method of micro-emulsion type cosmetics
JP2004099503A (en) Hgf production promoter and cosmetic containing the same
JP2004352697A (en) Tyrosinase expression inhibitor
JP2000095648A (en) Testosterone 5α-reductase inhibitor
FR2846236A1 (en) USE OF AN OXYSTEROL OR DERIVATIVE FOR THE TREATMENT OF DRY SKIN OR DRY SCALP
JP2019206490A (en) Mixed component having 5α-reductase inhibitory action, and composition for hair growth containing the same
JPH11116493A (en) Oral preparation for suppressing cell-cell adhesion
JPH06166609A (en) Whitening and beautifying agent
JP2011219462A (en) Cosmetic or phamaceutical composition containing kuzu flower extract
JP2003055162A5 (en)
BR112012025740B1 (en) Cosmetic preparation, and use of dihydrodesidrodi-isoeugenol
JP3165832B2 (en) Antiandrogens
JPH1179948A (en) Hair tonic and hair cosmetic, and preparation for external use for skin for suppressing sebum secretion
JPH09227341A (en) Anti-androgens
JPH11335232A (en) Testosterone 5α-reductase inhibitor
JP2001181144A (en) Hair restorer and hair cosmetic

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080622

Year of fee payment: 14

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D05

LAPS Cancellation because of no payment of annual fees